First-pass extracted concept

vascular smooth muscle cell phenotypic switching

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

phenotypic switching of vascular smooth muscle cells, VSMCs phenotypic switching

Evidence Snippets

Central to this pathological process is the phenotypic switching of vascular smooth muscle cells (VSMCs) from a quiescent contractile state to a proliferative, migratory, and synthetic phenotype.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1design needsupports2025Source 1DOI PubMed

The complexity of vascular smooth muscle cell regulatory networks and the limitations of current interventions support a need for integrative approaches combining molecular targeting with innovative delivery systems.

Claim 2mechanistic rolesupports2025Source 1DOI PubMed

Vascular smooth muscle cell phenotypic switching is a central mechanism in vein graft intimal hyperplasia.

Claim 3pathway regulationsupports2025Source 1DOI PubMed

PDGF-BB, TGF-β, MAPK, mTOR, NF-κB, and non-coding RNAs are described as key regulators of vascular smooth muscle cell phenotypic switching in vein graft intimal hyperplasia.

Claim 4state transitionsupports2025Source 1DOI PubMed

In vein graft pathology, vascular smooth muscle cells switch from a quiescent contractile state to a proliferative, migratory, and synthetic phenotype.